Alliance Pharmaceuticals

Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB
Telephone: +44 (0)1249 466 966
Fax: +44 (0)1249 466 977
WWW: http://www.alliancepharma.co.uk
Medical Information e-mail: medinfo@alliancepharma.co.uk
Summary of Product Characteristics last updated on the eMC: 03/11/2009
SPC Aquadrate 10% w/w Cream

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to separate SPCs covering individual presentations
Date of revision of text on the SPC:   05-Dec-2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

SmPC separated for Aquadrate and Hydromol Intensive
Updated on 06/04/2009 and displayed until 03/11/2009
Reasons for adding or updating:
  • Change to section 1 -Name of the Medicinal product
Date of revision of text on the SPC:   05-Dec-2008
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 1- The folllowing text has been added:


Hydromol Intensive

Updated on 25/05/2006 and displayed until 06/04/2009
Reasons for adding or updating:
  • Change to section 1 - trade name
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 (date of (partial) revision of the text
Date of revision of text on the SPC:   10/05/2006
Legal Category:   P
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 1 the name of the product has changed from Aquadrate Cream to Aquadrate 10% w/w Cream.
 
Section 4.8 (undesirable effects) local irritations (including erythema, burning or pruritus) [when applied to sensitive, moist or fissured skin] have been added and stinging has been removed.
Updated on 01/04/2005 and displayed until 25/05/2006
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change from the BAN of the active substance to the rINN
Updated on 01/04/2005 and displayed until 01/04/2005
Reasons for adding or updating:
  • Change to section 6.1 - List of Excipients
  • Change from the BAN of the active substance to the rINN
Updated on 17/05/2002 and displayed until 01/04/2005
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder

Active Ingredients/Generics

 
   urea


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk